The Society of Memorial Sloan-Kettering Cancer Center Company Profile

16:56 EDT 26th April 2015 | BioPortfolio


News Articles [3832 Associated News Articles listed on BioPortfolio]

MSK team makes key discovery in understanding immunotherapy's successes -- and its failures

(Memorial Sloan-Kettering Cancer Center) A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the unders...

MabVax Therapeutics, Inc. And Memorial Sloan-Kettering Cancer Center Report On Potential Use Of Dual-Labeled Antibody To Detect And Guide Surgical Removal Of Pancreatic Cancer

SAN DIEGO, Nov. 19, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) a clinical stage oncology drug development company in conjunction with the Department of Radiology at Memorial...

Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy’s Successes—And Its Failures

A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to i...

Fitch Releases Report on Memorial Sloan-Kettering Cancer Center, NY

Fitch Ratings has published a report on Memorial Sloan-Kettering Cancer Center, NY. The report is available at 'www.fitchratings.com'. Additional informat...

Memorial Sloan Kettering Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Recently added to the BioPortfolio report store, Memorial Sloan Kettering Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile is a new report from GlobalData published on 2...

Study shows new kind of targeted drug has promise for leukemia patients

A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD, a medic...

Report card on complementary therapies for breast cancer

Over eighty percent of breast cancer patients in the United States use complementary therapies following a breast cancer diagnosis, but there has been little science-based guidance to inform clinician...

Ambry Genetics, Dana-Farber Cancer Institute, Mayo Clinic, Memorial Sloan Kettering, University of Pennsylvania cancer news

PubMed Articles [8486 Associated PubMed Articles listed on BioPortfolio]

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.

We compared outcomes of adult patients receiving T-cell-depleted (TCD) hematopoietic SCT (HCT) without additional GVHD prophylaxis at Memorial Sloan Kettering Cancer Center (MSKCC, N=52), with those o...

Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.

Sentinel lymph node (SLN) positivity is an important prognostic factor in cutaneous melanoma. A nomogram has been developed at Memorial Sloan-Kettering Cancer Centre (MSKCC) to predict SLN positivity ...

Methods for the development of tumor-targeting bacteria.

Introduction: For at least two centuries, there have been reports that cancer patients infected with various bacteria had what appeared to be spontaneous remission. In the late nineteenth and early tw...

A Conversation with Susan Band Horwitz.

Introduction Susan Band Horwitz is a Distinguished Professor and holds the Falkenstein Chair in Cancer Research at Albert Einstein College of Medicine in New York. She is co-chair of the Department of...

Delirium and severe illness: Etiologies, severity of delirium and phenomenological differences.

Objective: Our aim was to examine the characteristics of delirium in the severely medically ill cancer population on the basis of sociodemographic and medical variables, delirium severity, and phenome...

Clinical Trials [3396 Associated Clinical Trials listed on BioPortfolio]

Measurement of Cancer-Related Risk Perception in Smokers

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Cen...

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy

With a major liver or pancreas operation, there is a chance that one will require a transfusion of blood products (either red blood cells or plasma). This may be necessary during the oper...

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes...

A Randomized Study of Sulindac in Oral Premalignant Lesions

The purpose of this study is to see if a drug called sulindac can prevent the development of changes in the mouth that are related to oral pre-cancer growths (oral epithelial dysplasia) or...

Behavioral Intervention For BMT/SCT Survivors

The purpose of this study is to understand how to help survivors of bone marrow transplant and stem cell transplant (BMT/SCT) with emotional distress. BMT/SCT has become a more common type...

Companies [3142 Associated Companies listed on BioPortfolio]

Memorial Sloan-Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center's tradition of care began more than 100 years ago. In 1884, the cornerstone of the New York Cancer Hospital -- what was later to become Memorial Hospital for Can...

The Society of Memorial Sloan-Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

The CMO’s Structure, Assets, and Goals

Optimer Pharmaceuticals

Optimer's core competence includes the development of innovative drugs for treating diseases that currently have no satisfactory therapy. These include antibiotics for drug-resistant bacterial infecti...

Mojave Therapeutics Incorporated

Mojave Therapeutics is building a new class of biopharmaceuticals that primes the immune system to fight cancer and viral diseases. Mojave’s core technologies, developed by leading researchers at Me...

More Information about "The Society of Memorial Sloan-Kettering Cancer Center" on BioPortfolio

We have published hundreds of The Society of Memorial Sloan-Kettering Cancer Center news stories on BioPortfolio along with dozens of The Society of Memorial Sloan-Kettering Cancer Center Clinical Trials and PubMed Articles about The Society of Memorial Sloan-Kettering Cancer Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Society of Memorial Sloan-Kettering Cancer Center Companies in our database. You can also find out about relevant The Society of Memorial Sloan-Kettering Cancer Center Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record